1. Interstitial lung diseases—can pathologists arrive at an etiology-based diagnosis? A critical update

   • Helmut H. Popper

   Review and Perspectives 07 December 2012 Pages: 1 - 26

   

2. Guideline on the requirements of external quality assessment programs in molecular pathology

   • J. Han van Krieken
   • Nicola Normanno
   • Elisabeth Dequeker

   Meeting Report 19 December 2012 Pages: 27 - 37

3. KRAS mutation analysis on low percentage of colon cancer cells: the importance of quality assurance

   • J. R. Dijkstra
   • D. A. M. Heideman
   • J. H. J. M. van Krieken

   Original Article 15 December 2012 Pages: 39 - 46

4. Diagnostic utility of MS-MLPA in DNA methylation profiling of adenocarcinomas and neuroendocrine carcinomas of the colon–rectum

   • Daniela Furlan
   • Nora Sahnane
   • Carlo Capella

   Original Article 09 December 2012 Pages: 47 - 56

   

5. PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis

   • Kathrin Ludwig
   • Matteo Fassan
   • Massimo Rugge

   Original Article 08 December 2012 Pages: 57 - 63

   

6. Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer

   • Tobias Ach
   • Katharina Zeitler
   • Tobias Ettl

   Original Article 15 December 2012 Pages: 65 - 72

   

7. Tumoral indoleamine 2,3-dioxygenase expression predicts poor outcome in laryngeal squamous cell carcinoma

   • Jin Ye
   • Hui Liu
   • Yuan Li

   Original Article 20 November 2012 Pages: 73 - 81

   

8. Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma

   • Ai Mogi
   • Kaori Koga
   • Kazuki Nabeshima

   Original Article 28 November 2012 Pages: 83 - 93

   

9. PDCD4 expression in thyroid neoplasia

   • Gianmaria Pennelli
   • Matteo Fassan
   • Massimo Rugge

   Original Article 05 December 2012 Pages: 95 - 100

   

10. Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma

    • Hiroshi Kitamura
    • Toshihiko Torigoe
    • Taiji Tsukamoto

    Original Article 20 November 2012 Pages: 101 - 107

    

11. Osteosarcoma of the hands and feet: a distinct clinico-pathological subgroup

    • Jakob K. Anninga
    • Piero Picci
    • Pancras C. W. Hogendoorn

    Original Article 05 December 2012 Pages: 109 - 120

    

12. CK19 expression should be tested prior to OSNA analysis of sentinel lymph nodes in breast cancer

    • Felip Vilardell
    • X. Matias-Guiu

    Letter to the Editor 14 November 2012 Pages: 121 - 121

13. CK19 testing prior to OSNA analysis: to stain or not to stain?

    • Dionysios D. Remoundos
    • Meera Joshi
    • Giles H. Cunnick

    Letter to the Editor 24 October 2012 Pages: 123 - 124

14. The pathophysiology of chagasic megacolon: beyond ICC…

    • Gabrio Bassotti
    • Vincenzo Villanacci

    Letter to the Editor 21 November 2012 Pages: 125 - 125

15. The development of chagasic megacolon requires severe denervation and the reduction in interstitial cells of Cajal number might be a contributing factor

    • Sheila Jorge Adad
    • Gisele Barbosa e Silva
    • Alessandro Adad Jammal

    Letter to the Editor 09 December 2012 Pages: 127 - 127